Vitalhub (TSE:VHI) Announces Quarterly Earnings Results

Vitalhub (TSE:VHI) released its quarterly earnings results on Wednesday. The company reported C$0.06 earnings per share (EPS) for the quarter, FiscalAI reports. Vitalhub had a return on equity of 1.47% and a net margin of 2.88%.The business had revenue of C$31.39 million during the quarter.

Vitalhub Trading Down 1.4%

VHI traded down C$0.11 during trading on Wednesday, hitting C$7.71. 140,379 shares of the company’s stock were exchanged, compared to its average volume of 345,743. Vitalhub has a 1 year low of C$7.60 and a 1 year high of C$14.64. The stock has a 50 day moving average price of C$8.34 and a 200 day moving average price of C$9.54. The firm has a market cap of C$486.66 million, a P/E ratio of 192.75, a price-to-earnings-growth ratio of 1.18 and a beta of 0.65.

Insiders Place Their Bets

In related news, Director Francis Nelson Shen bought 148,700 shares of the company’s stock in a transaction that occurred on Tuesday, December 23rd. The shares were acquired at an average cost of C$9.05 per share, for a total transaction of C$1,345,735.00. Following the acquisition, the director owned 148,700 shares in the company, valued at C$1,345,735. This represents a ∞ increase in their position. Also, Director Anthony Pius Shen acquired 5,470 shares of the company’s stock in a transaction dated Tuesday, December 23rd. The shares were purchased at an average price of C$9.23 per share, for a total transaction of C$50,488.10. Following the purchase, the director directly owned 5,470 shares of the company’s stock, valued at approximately C$50,488.10. This trade represents a ∞ increase in their ownership of the stock. 18.57% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on VHI shares. Royal Bank Of Canada decreased their price objective on Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating on the stock in a report on Monday, January 26th. Scotiabank reduced their target price on Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 4th. Finally, ATB Cormark Capital Markets decreased their price target on Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 10th. One analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of C$14.43.

Vitalhub Company Profile

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.